about
New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome.Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.Angiotensin in Critical Care.Angiotensin converting enzyme defects in shock: implications for future therapy
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The use of angiotensin II in distributive shock
@en
The use of angiotensin II in distributive shock
@nl
type
label
The use of angiotensin II in distributive shock
@en
The use of angiotensin II in distributive shock
@nl
prefLabel
The use of angiotensin II in distributive shock
@en
The use of angiotensin II in distributive shock
@nl
P2093
P2860
P1433
P1476
The use of angiotensin II in distributive shock
@en
P2093
Ermira Brasha-Mitchell
Laurence W Busse
Ziyad Alotaibi
P2860
P2888
P356
10.1186/S13054-016-1306-5
P577
2016-05-27T00:00:00Z
P6179
1010859739